11/21/2023 0 Comments 12264 el camino realAs explained further below, your firm’s website and twitter account make false or misleading claims regarding “Simple Drops” and “Klarity C-Drops” – specifically, they represent that these products are made with FDA approved components or are FDA-approved, when that is not the case. 321(g)(1), because they are intended for use in the cure, mitigation, treatment or prevention of disease. The claims on your website and other promotional materials establish that these products are drugs under section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. “Klarity C-Drops” product (cyclosporine 0.1%/chrondroitin sulfate).O Tim-Dor-Lat PF (timolol/dorzolamide/latanoprost), 0.5/2/0.005% O Tim-Brim-Dor PF 2 (timolol/brimonidine/dorzolamide), 0.5/0.15/2% O Pred-Nepaf (prednisolone acetate, nepafenac), 1/0.1%/mL O Pred-Gati (prednisolone acetate, gatifloxacin), 1/0.5%/mL O Pred-Gati-Nepaf (prednisolone acetate, gatifloxacin, nepafenac), 1/0.5/0.1%/mL O Moxi (moxifloxacin hydrochloride), 5mg/mL O Tri-Moxi-Vanc (triamcinolone acetonide, moxifloxacin, vancomycin), 15/1mg/10mg/mL O Tri-Moxi (triamcinolone acetonide, moxifloxacin hydrochloride), 15/1mg/ml Food and Drug Administration (FDA) has reviewed promotional materials disseminated by your firm, including the website at 1 where you take orders for the following compounded drug products: This is to advise your firm that the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |